Literature DB >> 21750084

Frequency of pain crises in sickle cell anemia and its relationship with the sympatho-vagal balance, blood viscosity and inflammation.

Danitza Nebor1, Andre Bowers, Marie-Dominique Hardy-Dessources, Jennifer Knight-Madden, Marc Romana, Harvey Reid, Jean-Claude Barthélémy, Vanessa Cumming, Olivier Hue, Jacques Elion, Marvin Reid, Philippe Connes.   

Abstract

BACKGROUND: Recent evidence suggests that autonomic nervous system activity could be involved in the pathophysiology of sickle cell disease, but it is unclear whether differences in autonomic nervous system activity are detectable during steady state in patients with mild and severe disease. The aim of the present study was to compare the autonomic nervous system activity, blood rheology, and inflammation in patients with sickle cell anemia according to the frequency of acute pain crisis. DESIGN AND METHODS: Twenty-four healthy volunteers, 20 patients with sickle cell anemia with milder disease, and 15 patients with sickle cell anemia with more severe disease were recruited. Milder disease was defined as having no pain crisis within the previous year. More severe disease was defined as having had within the previous year three or more pain crises which were documented by a physician and required treatment with narcotics. The autonomic nervous system activity was determined by spectral analysis of nocturnal heart rate variability. Blood viscosity determination and measurements of several inflammatory markers (interleukin-6, soluble vascular cell adhesion molecule-1, soluble CD40 ligand and sL-selectin) were made on blood samples collected in steady-state conditions.
RESULTS: Results showed that: 1) patients who had suffered more frequent pain crises had lower parasympathetic activity and greater sympatho-vagal imbalance than both controls and patients with milder disease. However, when adjusted for age, no significant difference was detected between the two sickle cell anemia patient groups; 2) patients who had suffered more frequent pain crises had higher blood viscosity than patients with milder disease, and this was not dependent on age.
CONCLUSIONS: Results from the present study indicate that both the autonomic nervous system activity and blood viscosity are impaired in patients with sickle cell anemia exhibiting high frequency of pain crisis in comparison with those who did not experience a crisis within the previous year.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21750084      PMCID: PMC3208675          DOI: 10.3324/haematol.2011.047365

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  38 in total

1.  Even slight movements disturb analysis of cardiovascular dynamics.

Authors:  J O Fortrat; C Formet; J Frutoso; C Gharib
Journal:  Am J Physiol       Date:  1999-07

2.  Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin.

Authors:  L V Borovikova; S Ivanova; M Zhang; H Yang; G I Botchkina; L R Watkins; H Wang; N Abumrad; J W Eaton; K J Tracey
Journal:  Nature       Date:  2000-05-25       Impact factor: 49.962

Review 3.  Heart rate variability.

Authors:  Harald M Stauss
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-11       Impact factor: 3.619

4.  Childhood sickle cell crises: clinical severity, inflammatory markers and the role of interleukin-8.

Authors:  Maryse Etienne-Julan; Marie-Sylvaine Belloy; Monique Decastel; Samuel Dougaparsad; Sylvie Ravion; Marie-Dominique Hardy-Dessources
Journal:  Haematologica       Date:  2004-07       Impact factor: 9.941

5.  Heart rate variability and ventricular late potentials in beta-thalassemia major.

Authors:  Ferdinando Franzoni; Fabio Galetta; Carmine Di Muro; Giuliana Buti; Ferdinando Pentimone; Gino Santoro
Journal:  Haematologica       Date:  2004-02       Impact factor: 9.941

Review 6.  Sickle-cell disease.

Authors:  Marie J Stuart; Ronald L Nagel
Journal:  Lancet       Date:  2004 Oct 9-15       Impact factor: 79.321

7.  The painful crisis of homozygous sickle cell disease. A study of the risk factors.

Authors:  K F Baum; D T Dunn; G H Maude; G R Serjeant
Journal:  Arch Intern Med       Date:  1987-07

8.  Very low frequency power of heart rate variability is a powerful predictor of clinical prognosis in patients with congestive heart failure.

Authors:  Mitsuyoshi Hadase; Akihiro Azuma; Kan Zen; Satoshi Asada; Tatsuya Kawasaki; Tadaaki Kamitani; Shingo Kawasaki; Hiroki Sugihara; Hiroaki Matsubara
Journal:  Circ J       Date:  2004-04       Impact factor: 2.993

Review 9.  Sickle red cell microrheology and sickle blood rheology.

Authors:  Samir K Ballas; Narla Mohandas
Journal:  Microcirculation       Date:  2004-03       Impact factor: 2.628

10.  Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation.

Authors:  Hong Wang; Man Yu; Mahendar Ochani; Carol Ann Amella; Mahira Tanovic; Seenu Susarla; Jian Hua Li; Haichao Wang; Huan Yang; Luis Ulloa; Yousef Al-Abed; Christopher J Czura; Kevin J Tracey
Journal:  Nature       Date:  2002-12-22       Impact factor: 49.962

View more
  32 in total

1.  Using the hemoglobin switch for the treatment of sickle cell disease.

Authors:  Jan Cools
Journal:  Haematologica       Date:  2012-02       Impact factor: 9.941

2.  Individuals with sickle cell disease have a significantly greater vasoconstriction response to thermal pain than controls and have significant vasoconstriction in response to anticipation of pain.

Authors:  Maha Khaleel; Mammen Puliyel; Payal Shah; John Sunwoo; Roberta M Kato; Patjanaporn Chalacheva; Wanwara Thuptimdang; Jon Detterich; John C Wood; Jennie Tsao; Lonnie Zeltzer; Richard Sposto; Michael C K Khoo; Thomas D Coates
Journal:  Am J Hematol       Date:  2017-08-17       Impact factor: 10.047

3.  Hydroxyurea treatment does not increase blood viscosity and improves red blood cell rheology in sickle cell anemia.

Authors:  Nathalie Lemonne; Keyne Charlot; Xavier Waltz; Samir K Ballas; Yann Lamarre; Ketty Lee; Régine Hierso; Catherine Connes; Maryse Etienne-Julan; Marc Romana; Philippe Connes
Journal:  Haematologica       Date:  2015-07-02       Impact factor: 9.941

4.  CAREST--Multilingual Regional Integration for Health Promotion and Research on Sickle Cell Disease and Thalassemia.

Authors:  Jennifer Knight-Madden; Marc Romana; Rinaldo Villaescusa; Marvin Reid; Maryse Etienne-Julan; Laurence Boutin; Gisèle Elana; Narcisse Elenga; Gillian Wheeler; Ketty Lee; Rosa Nieves; Althea Jones Lecointe; Marie-Laure Lalanne-Mistrih; Gylna Loko; Lisiane Keclard-Christophe; Marie-Dominique Hardy-Dessources
Journal:  Am J Public Health       Date:  2016-03-21       Impact factor: 9.308

Review 5.  Negative health implications of sickle cell trait in high income countries: from the football field to the laboratory.

Authors:  Nigel S Key; Philippe Connes; Vimal K Derebail
Journal:  Br J Haematol       Date:  2015-03-07       Impact factor: 6.998

6.  Remote monitoring of pain and symptoms using wireless technology in children and adolescents with sickle cell disease.

Authors:  Eufemia Jacob; Joana Duran; Jennifer Stinson; Mary Ann Lewis; Lonnie Zeltzer
Journal:  J Am Assoc Nurse Pract       Date:  2012-07-12       Impact factor: 1.165

7.  Hemorheological risk factors of acute chest syndrome and painful vaso-occlusive crisis in children with sickle cell disease.

Authors:  Yann Lamarre; Marc Romana; Xavier Waltz; Marie-Laure Lalanne-Mistrih; Benoît Tressières; Lydia Divialle-Doumdo; Marie-Dominique Hardy-Dessources; Jens Vent-Schmidt; Marie Petras; Cedric Broquere; Frederic Maillard; Vanessa Tarer; Maryse Etienne-Julan; Philippe Connes
Journal:  Haematologica       Date:  2012-06-11       Impact factor: 9.941

8.  End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain.

Authors:  Ann T Farrell; Julie Panepinto; C Patrick Carroll; Deepika S Darbari; Ankit A Desai; Allison A King; Robert J Adams; Tabitha D Barber; Amanda M Brandow; Michael R DeBaun; Manus J Donahue; Kalpna Gupta; Jane S Hankins; Michelle Kameka; Fenella J Kirkham; Harvey Luksenburg; Shirley Miller; Patricia Ann Oneal; David C Rees; Rosanna Setse; Vivien A Sheehan; John Strouse; Cheryl L Stucky; Ellen M Werner; John C Wood; William T Zempsky
Journal:  Blood Adv       Date:  2019-12-10

9.  Severe proliferative retinopathy is associated with blood hyperviscosity in sickle cell hemoglobin-C disease but not in sickle cell anemia.

Authors:  Clément Lemaire; Yann Lamarre; Nathalie Lemonne; Xavier Waltz; Sadri Chahed; Florence Cabot; Ioana Botez; Benoit Tressieres; Marie-Laure Lalanne-Mistrih; Maryse Etienne-Julan; Philippe Connes
Journal:  Clin Hemorheol Microcirc       Date:  2013-01-01       Impact factor: 2.375

10.  Psychological aspects and hospitalization for pain crises in youth with sickle-cell disease.

Authors:  Jennie C I Tsao; Eufemia Jacob; Laura C Seidman; Mary A Lewis; Lonnie K Zeltzer
Journal:  J Health Psychol       Date:  2013-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.